GB0821693D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB0821693D0
GB0821693D0 GBGB0821693.9A GB0821693A GB0821693D0 GB 0821693 D0 GB0821693 D0 GB 0821693D0 GB 0821693 A GB0821693 A GB 0821693A GB 0821693 D0 GB0821693 D0 GB 0821693D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0821693.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma SA
Original Assignee
UCB Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Pharma SA filed Critical UCB Pharma SA
Priority to GBGB0821693.9A priority Critical patent/GB0821693D0/en
Publication of GB0821693D0 publication Critical patent/GB0821693D0/en
Priority to PCT/GB2009/002741 priority patent/WO2010061180A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36Sulfur atom
    • C07D473/38Sulfur atom attached in position 6
GBGB0821693.9A 2008-11-27 2008-11-27 Therapeutic agents Ceased GB0821693D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0821693.9A GB0821693D0 (en) 2008-11-27 2008-11-27 Therapeutic agents
PCT/GB2009/002741 WO2010061180A1 (fr) 2008-11-27 2009-11-23 Dérivés de quinoléine en tant qu’inhibiteurs de pi3-kinase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0821693.9A GB0821693D0 (en) 2008-11-27 2008-11-27 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB0821693D0 true GB0821693D0 (en) 2008-12-31

Family

ID=40230932

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0821693.9A Ceased GB0821693D0 (en) 2008-11-27 2008-11-27 Therapeutic agents

Country Status (2)

Country Link
GB (1) GB0821693D0 (fr)
WO (1) WO2010061180A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009009968A (es) * 2007-03-23 2009-10-08 Amgen Inc Compuestos heterociclicos y sus usos.
ES2446417T3 (es) 2007-03-23 2014-03-07 Amgen Inc. Derivados de quinolina o quinoxalina sustituidos en 3 y su uso como inhibidores de fosfatidilinositol 3-cinasa (PI3K)
JP5599783B2 (ja) 2008-05-30 2014-10-01 アムジエン・インコーポレーテツド Pi3キナーゼの阻害薬
WO2010151740A2 (fr) * 2009-06-25 2010-12-29 Amgen Inc. Composés hétérocycliques et utilisations correspondantes
JP2012531435A (ja) 2009-06-25 2012-12-10 アムジエン・インコーポレーテツド PI3K阻害剤としての4H−ピリド[1,2−a]ピリミジン−4−オン誘導体
EP2445902A2 (fr) 2009-06-25 2012-05-02 Amgen, Inc Composés hétérocycliques et leurs utilisations en tant qu'inhibiteurs de l'activité des pi3k
BR112012000660A2 (pt) 2009-06-25 2016-11-16 Amgen Inc compostos heterociclos e seus usos
MX2012006953A (es) 2009-12-18 2012-10-09 Amgen Inc Compuestos heterociclicos y sus usos.
UY33304A (es) 2010-04-02 2011-10-31 Amgen Inc Compuestos heterocíclicos y sus usos
WO2012003278A1 (fr) 2010-06-30 2012-01-05 Amgen Inc. Quinoléines en tant qu'inhibiteurs de pi3k
US8759371B2 (en) 2010-07-01 2014-06-24 Amgen Inc. Heterocyclic compounds and their uses
MX2013005567A (es) 2010-11-17 2013-10-30 Amgen Inc Derivados de quinolina como inhibidores de pik3.
US9637488B2 (en) * 2015-01-29 2017-05-02 Fuqiang Ruan Heterocyclic compounds as inhibitors of class I PI3KS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009009968A (es) * 2007-03-23 2009-10-08 Amgen Inc Compuestos heterociclicos y sus usos.

Also Published As

Publication number Publication date
WO2010061180A1 (fr) 2010-06-03

Similar Documents

Publication Publication Date Title
GB0811304D0 (en) Therapeutic agents
EP2117311A4 (fr) Agents thérapeutiques
GB0811643D0 (en) New therapeutic agents
GB0908957D0 (en) Therapeutic agents
GB0819593D0 (en) Therapeutic agents
HRP20130041T8 (en) Therapeutic agents
GB0821693D0 (en) Therapeutic agents
GB0723747D0 (en) Therapeutic agents
GB0812309D0 (en) Therapeutic agents
GB0805818D0 (en) Therapeutic agents
GB0801080D0 (en) Therapeutic agents
GB0801081D0 (en) Therapeutic agents
GB0724340D0 (en) Novel Therapeutic Agents
EP2454276A4 (fr) Agents thérapeutiques
GB0723748D0 (en) Therapeutic agents
GB0811715D0 (en) Therapeutic agents
GB0910493D0 (en) Therapeutic agents
GB0815177D0 (en) Therapeutic agents
GB0812558D0 (en) Therapeutic agents
GB0820275D0 (en) Therapeutic agents
GB0801082D0 (en) Therapeutic agents
GB0812563D0 (en) Therapeutic agents
GB0815765D0 (en) New therapeutic agents
GB0723751D0 (en) Therapeutic agents
GB0723749D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)